Breaking News Instant updates and real-time market news.

NTRI

Nutrisystem

$56.95

1.8 (3.26%)

, GOOG

Alphabet

$953.42

-2.57 (-0.27%)

09:18
07/18/17
07/18
09:18
07/18/17
09:18

Google Trends results suggest beat/raise for Nutrisystem, says Craig-Hallum

Craig-Hallum analyst Alex Fuhrman says that given continued strong Google (GOOG; GOOGL) searches for the Nutrisystem (NTRI) brand, the latter should be on track to report/guide to stronger than expected results for Q2/Q3. The analyst reiterates a Buy rating and $70 on Nutrisystem's shares.

NTRI

Nutrisystem

$56.95

1.8 (3.26%)

GOOG

Alphabet

$953.42

-2.57 (-0.27%)

GOOGL

Alphabet Class A

$975.96

-0.95 (-0.10%)

  • 19

    Jul

  • 24

    Jul

  • 26

    Jul

NTRI Nutrisystem
$56.95

1.8 (3.26%)

06/12/17
SIDC
06/12/17
UPGRADE
Target $46
SIDC
Buy
Nutrisystem upgraded to Buy from Neutral at Sidoti
Sidoti analyst Frank Camma upgraded Nutrisystem to Buy citing the recent pullback in shares and maintained a $60 price target. Camma said Nutrisystem continues to execute on growing market share and said it has the strongest the fundamentals among the publicly traded diet management companies, and believes the stock deserves its premium valuation.
05/08/17
DADA
05/08/17
INITIATION
Target $64
DADA
Buy
Nutrisystem initiated with a Buy at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated Nutrisystem with a Buy rating and $64 price target.
04/27/17
CHLM
04/27/17
NO CHANGE
Target $70
CHLM
Buy
Nutrisystem price target raised to $70 from $60 at Craig-Hallum
Craig-Hallum analyst Alex Fuhrman raised his price target for Nutrisystem to $70 from $60 after another beat and raise as the company continues into multi-year period of accelerated growth. The analyst reiterates a Buy rating on the shares.
04/27/17
WDLK
04/27/17
DOWNGRADE
Target $60
WDLK
Hold
Nutrisystem downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Mitchell Pinheiro downgraded Nutrisystem to Hold but raised his price target for the shares to $60 from $52 following the company's Q1 results.
GOOG Alphabet
$953.42

-2.57 (-0.27%)

07/18/17
NEED
07/18/17
NO CHANGE
Target $1050
NEED
Buy
EU fine to reduce Alphabet Q2 EPS by $4 per share, says Needham
Needham analyst Kerry Rice estimates the $2.74B EU fine reduces Alphabet's EPS by about $3.90/share. With the company reporting its Q2 results on July 24th, the analyst expects Alphabet to post results at least in-line with his estimates. Rice reiterates a Buy rating and $1,050 price target on the shares.
07/18/17
OPCO
07/18/17
NO CHANGE
Target $1050
OPCO
Outperform
Alphabet estimates lowered after EU fine at Oppenheimer
Oppenheimer analyst Jason Helfstein is updating his model for Alphabet to reflect the $2.74B European Commission fine, which will be reported as a separate operating line in the Q2 earnings release. As such, the analyst treats it as an operating expense that reduces his Q2 and FY17 estimates for Operating Income, Google Segment Operating Income and GAAP Net Income. The fine is non-deductible, and as such Helfstein removes the full $2.74B from his post-tax earnings, increasing his effective tax rate estimate from 20% to 33%. He reiterates an Outperform rating and $1,050 price target on the shares.
07/17/17
MKMP
07/17/17
NO CHANGE
Target $1170
MKMP
Buy
Alphabet checks point to strong demand trends, says MKM Partners
MKM Partners analyst Rob Sanderson said anecdotal evidence from ad agencies suggests that demand trends for digital advertising generally, and for Alphabet in particular, remain strong. Concerns around YouTube have quieted down "considerably," added Sanderson, who keeps a Buy rating on Google's parent ahead of its upcoming earnings report.
07/13/17
MONN
07/13/17
NO CHANGE
MONN
PayPal price target raised to $70 from $54 at Monness Crespi
After conducting checks, Monness Crespi analyst James Cakmak raised his price target on PayPal (PYPL) . He says that the market is failing to appreciate the boost to PayPal's margins that its Pay with Venmo product will bring. The analyst also expects PayPal to make an international deal with Alphabet's (GOOG,GOOGL) Android and he thinks that its newly announced deal with Apple (AAPL) "diminishes competitive risks." Cakmak adds that the company can benefit meaningfully from a partnership with Facebook (FB), The analyst keeps a Buy rating on PayPal.
GOOGL Alphabet Class A
$975.96

-0.95 (-0.10%)

07/11/17
MSCO
07/11/17
NO CHANGE
Target $305
MSCO
Equal Weight
Morgan Stanley sees Tesla as 'expensive call option' on next-gen transportation
Following the recent pullback in Tesla (TSLA) shares, Morgan Stanley analyst Adam Jonas revisited his thoughts on the stock and concluded that, at current valuation, Tesla remains "a rather expensive call option" on the addressable markets of next-generation transportation and energy. With protectionism an increasing worry as Tesla threatens to "flood" international markets with its electric vehicles, Jonas sticks by his view that "very large and well capitalized" tech competitors, such as Apple (AAPL) and Alphabet (GOOGL) will be making "increasingly conspicuous" efforts to encroach on Tesla's territory. He maintains an Equal Weight rating and $305 price target on Tesla shares.

TODAY'S FREE FLY STORIES

10:15
12/14/17
12/14
10:15
12/14/17
10:15
General news
U.S. business inventories dipped 0.1% in October with sales up 0.6% »

U.S. business inventories…

10:15
12/14/17
12/14
10:15
12/14/17
10:15
General news
Breaking General news story  »

Week of 12/8 EIA Natural…

LUXTY

Luxottica

$59.55

0.05 (0.08%)

, LUX

Symbol now LUXTY

10:12
12/14/17
12/14
10:12
12/14/17
10:12
Periodicals
Luxottica, Essilor deal expected to win unconditional EU approval, Reuters says »

The proposed $56.8B…

LUXTY

Luxottica

$59.55

0.05 (0.08%)

LUX

Symbol now LUXTY

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.12

-0.0046 (-3.60%)

10:10
12/14/17
12/14
10:10
12/14/17
10:10
Hot Stocks
Jaguar Health, Seed Mena enter collaboration agreement with Equilevia »

Jaguar Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

SLV

iShares Silver Trust

$14.96

-0.19 (-1.25%)

10:10
12/14/17
12/14
10:10
12/14/17
10:10
Options
Second day of interest in iShares Silver call options »

Second day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$5.03

0.02 (0.40%)

10:04
12/14/17
12/14
10:04
12/14/17
10:04
Hot Stocks
Pandora to offer ad-supported listeners access to on-demand listening »

Pandora announced it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHDX

Genomic Health

$28.00

-2.05 (-6.82%)

10:02
12/14/17
12/14
10:02
12/14/17
10:02
Hot Stocks
Genomic Health heads higher after Bloomberg report on sale exploration »

Shares of Genomic Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:01
12/14/17
12/14
10:01
12/14/17
10:01
General news
Business Inventories data reported »

October Business…

GOGO

Gogo

$10.39

-0.22 (-2.07%)

, DAL

Delta Air Lines

$54.30

0.67 (1.25%)

10:01
12/14/17
12/14
10:01
12/14/17
10:01
Hot Stocks
Gogo higher after Delta buys 100 planes with 2Ku Wi-Fi »

Shares of Gogo (GOGO) are…

GOGO

Gogo

$10.39

-0.22 (-2.07%)

DAL

Delta Air Lines

$54.30

0.67 (1.25%)

EADSY

Airbus

$26.16

0.62 (2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AGN

Allergan

$169.34

0.1 (0.06%)

10:01
12/14/17
12/14
10:01
12/14/17
10:01
Rumors
Rumor moving shares of Allergan »

Rumor: Allergan moves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

TEVA

Teva

$18.00

2.2982 (14.64%)

10:00
12/14/17
12/14
10:00
12/14/17
10:00
Options
Teva in-the-money calls active as shares spike »

Teva in-the-money calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

10:00
12/14/17
12/14
10:00
12/14/17
10:00
General news
U.S. December Markit manufacturing PMI jumped 1.1 points to 55.0 »

U.S. December Markit…

GBTC

Bitcoin Investment Trust

$2,335.00

62 (2.73%)

09:59
12/14/17
12/14
09:59
12/14/17
09:59
Periodicals
Citron puts fair value of Bitcoin Investment Trust at $1,600 »

Citron Research just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAN

Banco Santander

$6.67

0.0832 (1.26%)

09:58
12/14/17
12/14
09:58
12/14/17
09:58
Hot Stocks
Breaking Hot Stocks news story on Banco Santander »

Banco Santander raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$108.26

0.65 (0.60%)

, FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

09:57
12/14/17
12/14
09:57
12/14/17
09:57
Recommendations
Disney, 21st Century Fox analyst commentary  »

Fox deal brings…

DIS

Disney

$108.26

0.65 (0.60%)

FOXA

21st Century Fox

$32.75

-1.35 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

TIF

Tiffany

$100.49

4.39 (4.57%)

, MYL

Mylan

$39.53

0.24 (0.61%)

09:55
12/14/17
12/14
09:55
12/14/17
09:55
Options
Early notable gainers among liquid option names on December 14th »

Notable gainers among…

TIF

Tiffany

$100.49

4.39 (4.57%)

MYL

Mylan

$39.53

0.24 (0.61%)

MAT

Mattel

$15.59

0.97 (6.63%)

ESRX

Express Scripts

$68.57

0.01 (0.01%)

MCK

McKesson

$158.35

3.14 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

EACQ

Easterly Acquisition Corp

09:55
12/14/17
12/14
09:55
12/14/17
09:55
Conference/Events
Easterly Acquisition Corp to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

VTGN

VistaGen Therapeutics

$1.17

-0.01 (-0.85%)

09:53
12/14/17
12/14
09:53
12/14/17
09:53
Hot Stocks
Breaking Hot Stocks news story on VistaGen Therapeutics »

Sabby reports 9.15%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHDX

Genomic Health

$28.00

-2.05 (-6.82%)

09:52
12/14/17
12/14
09:52
12/14/17
09:52
Hot Stocks
Breaking Hot Stocks news story on Genomic Health »

Genomic Health jumps 12%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHDX

Genomic Health

$28.00

-2.05 (-6.82%)

09:51
12/14/17
12/14
09:51
12/14/17
09:51
Periodicals
Breaking Periodicals news story on Genomic Health »

Genomic Health exploring…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$267.20

0.45 (0.17%)

09:50
12/14/17
12/14
09:50
12/14/17
09:50
Options
Partial unwind in SPY vertical call spread locks in 370% winner »

Partial unwind in SPY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:50
12/14/17
12/14
09:50
12/14/17
09:50
General news
U.S. business inventories preview: »

U.S. business inventories…

09:46
12/14/17
12/14
09:46
12/14/17
09:46
General news
PMI Composite Flash Manufacturing â€' Level data reported »

December PMI Composite…

09:46
12/14/17
12/14
09:46
12/14/17
09:46
General news
PMI Composite Flash â€' Level data reported »

December PMI Composite…

09:45
12/14/17
12/14
09:45
12/14/17
09:45
General news
The U.S. trade price report overshot estimates »

The U.S. trade price…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.